September/October 2011

New Drugs, First Generics, and the Near-Term Pipeline 2012

October 06, 2011

The American Journal of Pharmacy Benefits

Approvals of potential blockbuster drugs represent a new source of revenue for pharmaceutical manufacturers, who will experience significant income loss from generic competition in 2011-2012.

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

October 05, 2011

The American Journal of Pharmacy Benefits

Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

October 01, 2011

The American Journal of Pharmacy Benefits

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.

The Opportunity to Go OTC

September 30, 2011

The American Journal of Pharmacy Benefits

The potential OTC availability of Lipitor and other prescription drugs raises questions regarding value, safety, appropriateness, and insurance coverage.